David Santamarı́a
Impact in
- Oncology top 2%
- Cancer-related Molecular Pathways
- Cell Biology top 1%
- Microtubule and mitosis dynamics
Papers in
-
- Epigenetics and DNA Methylation 8
- DNA Repair Mechanisms 7
- Melanoma and MAPK Pathways 6
- RNA modifications and cancer 5
- Oncology 18
- Cancer-related Molecular Pathways 13
- Co-authors
- Mariano Barbacid (20 shared papers)Pierre Dubus (7 shared papers)Marcos Malumbres (7 shared papers)Sagrario Ortega (5 shared papers)Cédric Barrière (2 shared papers)Sarah L. Hunt (1 shared paper)Kathryn Newton (1 shared paper)Claudine Tardy (1 shared paper)
- Journals
- Molecular Oncology (3 papers)Nature (3 papers)Journal of Biological Chemistry (3 papers)Cell (2 papers)Cancer Cell (2 papers)
- Partner nations
- SpainFranceUnited States
In The Last Decade
David Santamarı́a
43 papers receiving 3.3k citations
David Santamarı́a's Hit Papers
Peers
Comparison fields: 5 of 102
- Oncology 1.4k
- Cell Biology 727
- Molecular Biology 2.1k
- Cancer Research 403
- Pulmonary and Respiratory Medicine 673
Countries citing papers authored by David Santamarı́a
This map shows the geographic impact of David Santamarı́a's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Santamarı́a with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Santamarı́a more than expected).
Fields of papers citing papers by David Santamarı́a
This network shows the impact of papers produced by David Santamarı́a. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Santamarı́a. The network helps show where David Santamarı́a may publish in the future.
Co-authors
The 25 scholars most cited alongside David Santamarı́a, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 43 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Cdk1 is sufficient to drive the mammalian cell cycle Hit paper breakdown → | 2007 | 822 |
| 2 | Mammalian Cells Cycle without the D-Type Cyclin-Dependent Kinases Cdk4 and Cdk6 Hit paper breakdown → | 2004 | 613 |
| 3 | 2010 | 333 | |
| 4 | 2011 | 224 | |
| 5 | 2018 | 191 | |
| 6 | 2016 | 137 | |
| 7 | 2006 | 131 | |
| 8 | 2012 | 95 | |
| 9 | 2007 | 89 | |
| 10 | 2017 | 71 | |
| 11 | 2019 | 56 | |
| 12 | 2011 | 53 | |
| 13 | 2009 | 52 | |
| 14 | 2011 | 52 | |
| 15 | 2014 | 50 | |
| 16 | 2015 | 44 | |
| 17 | 1998 | 31 | |
| 18 | 2005 | 31 | |
| 19 | 2000 | 29 | |
| 20 | 2014 | 28 |
About David Santamarı́a
David Santamarı́a is a scholar working on Molecular Biology, Oncology, Cell Biology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 43 papers that have together received 3.4k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (13 papers), Microtubule and mitosis dynamics (9 papers), Epigenetics and DNA Methylation (8 papers), DNA Repair Mechanisms (7 papers), Melanoma and MAPK Pathways (6 papers), Cancer Genomics and Diagnostics (6 papers), Lung Cancer Treatments and Mutations (6 papers) and RNA modifications and cancer (5 papers). The work is most often cited by research in Oncology (1.4k citations), Cell Biology (727 citations), Molecular Biology (2.1k citations), Cancer Research (403 citations) and Pulmonary and Respiratory Medicine (673 citations). David Santamarı́a has collaborated with scholars based in Spain, France and United States. Frequent co-authors include Mariano Barbacid, Pierre Dubus, Marcos Malumbres, Sagrario Ortega, Cédric Barrière, Sarah L. Hunt, Kathryn Newton, Claudine Tardy, Javier F. Cáceres and Rocı́o Sotillo. Their work appears in journals such as Molecular Oncology, Nature, Journal of Biological Chemistry, Cell and Cancer Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.